Health Market Science, a King of Prussia, PA-based data and analytics provider for the healthcare industry, has raised $6.1m in a Series B financing.
Cross Atlantic Capital Partners, which committed $4m, led the round, with follow-on investments from other institutional investors, including Edison Venture Fund.
The investment will enable the company to accelerate development of its industry technology platform and compliance solutions. Health Market Science provides data, analytics, software and regulatory compliance solutions for different segments of the healthcare industry in the United States, including pharmaceutical, medical device, pharmacy, and PBM.
In conjunction with the funding, Richard Fox will join the company’s Board of Directors.